Unacylated ghrelin induces oxidative stress resistance in a glucose intolerance and peripheral artery disease mouse model by restoring endothelial cell MIR-126 expression

Diabetes

Volumn 64, Issue 4, 2015, Pages 1370-1382

  Togliatto, Gabriele ^a   Trombetta, Antonella ^a   Dentelli, Patrizia ^a   Gallo, Sara ^a   Rosso, Arturo ^a   Cotogni, Paolo ^b   Granata, Riccarda ^a   Falcioni, Rita ^c   Delale, Thomas ^d   Ghigo, Ezio ^a   Brizzi, Maria Felice ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCOSE; HISTONE H3; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA 126; PROTEIN P53; SIRTUIN 1; SMALL INTERFERING RNA; VASCULAR CELL ADHESION MOLECULE 1; MICRORNA; MIRN126 MICRORNA, MOUSE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEACETYLATION; ENDOTHELIUM CELL; FUNCTIONAL DISEASE; GLUCOSE INTOLERANCE; IN VIVO STUDY; LIMB ISCHEMIA; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; HINDLIMB; ISCHEMIA; METABOLISM; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GHRELIN; GLUCOSE INTOLERANCE; HINDLIMB; ISCHEMIA; MALE; MICE; MICRORNAS; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE; SIRTUIN 1; SUPEROXIDE DISMUTASE;

EID: 84929143556     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0991     Document Type: Article

References (49)

1. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation 1996; 94: 3026-3049
2. Gili M, Orsello A, Gallo S, Brizzi MF. Diabetes-associated macrovascular complications: Cell-based therapy a new tool? Endocrine 2013;44: 557-575
3. Pitocco D, Tesauro M, Alessandro R, Ghirlanda G, Cardillo C. Oxidative stress in diabetes: Implications for vascular and other complications. Int J Mol Sci 2013;14: 21525-21550
4. Jezek P, Hlavatá L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 2005;37: 2478-2503
5. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107: 1058-1070
6. El-Osta A. Glycemic memory. Curr Opin Lipidol 2012;23: 24-29
7. Cooper ME, El-Osta A. Epigenetics: Mechanisms and implications for diabetic complications. Circ Res 2010;107: 1403-1413
8. Paneni F, Volpe M, Lüscher TF, Cosentino F. SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: Bringing all the strands together. Diabetes 2013;62: 1800-1807
9. El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008;205: 2409-2417
10. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Eur Heart J 2013;34: 2436-2443
11. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 2008;105: 1516-1521
12. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107: 810-817
13. Zhou S, Chen HZ, Wan YZ, et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res 2011;109: 639-648
14. Das C, Lucia MS, Hansen KC, Tyler JK. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 2009;459: 113-117
15. Perera GB, Lyden SP. Current trends in lower extremity revascularization. Surg Clin North Am 2007;87: 1135-1147, x
16. Cieri E, Lenti M, De Rango P, Isernia G, Marucchini A, Cao P. Functional ability in patients with critical limb ischaemia is unaffected by successful revascularisation. Eur J Vasc Endovasc Surg 2011;41: 256-263
17. Togliatto G, Trombetta A, Dentelli P, et al. Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes 2010;59: 1016-1025
18. Granata R, Settanni F, Julien M, et al. Des-acyl ghrelin fragments and analogues promote survival of pancreatic β-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats. J Med Chem 2012;55: 2585-2596
19. Togliatto G, Trombetta A, Dentelli P, et al. Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression. J Am Heart Assoc 2013;2: E000376
20. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402: 656-660
21. Lear PV, Iglesias MJ, Feijóo-Bandín S, et al. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. Endocrinology 2010;151: 3286-3298
22. van der Lely AJ, Tschöp M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004;25: 426-457
23. Kojima M, Kangawa K. Ghrelin: Structure and function. Physiol Rev 2005;85: 495-522
24. Barazzoni R, Zanetti M, Ferreira C, et al. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J Clin Endocrinol Metab 2007;92: 3935-3940
25. Hellingman AA, Bastiaansen AJ, de Vries MR, et al. Variations in surgical procedures for hind limb ischaemia mouse models result in differences in collateral formation. Eur J Vasc Endovasc Surg 2010;40: 796-803
26. Nagaya N, Uematsu M, Kojima M, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001;104: 1430-1435
27. Porporato PE, Filigheddu N, Reano S, et al. Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest 2013;123: 611-622
28. Bosch-Marce M, Okuyama H, Wesley JB, et al. Effects of aging and hypoxiainducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007;101: 1310-1318
29. Zeoli A, Dentelli P, Rosso A, et al. Interleukin-3 promotes expansion of hemopoietic-derived CD45+ angiogenic cells and their arterial commitment via STAT5 activation. Blood 2008;112: 350-361
30. Brizzi MF, Dentelli P, Rosso A, et al. RAGE-and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: A possible role in the development and progression of diabetic nephropathy. FASEB J 2004;18: 1249-1251
31. Togliatto G, Trombetta A, Dentelli P, Rosso A, Brizzi MF. MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose-and AGE-mediated vascular cell damage. Diabetologia 2011;54: 1930-1940
32. Musarò A, Barberi L. Isolation and culture of mouse satellite cells. Methods Mol Biol 2010;633: 101-111
33. Brizzi MF, Dentelli P, Pavan M, et al. Diabetic LDL inhibits cell-cycle progression via STAT5B and p21(waf). J Clin Invest 2002;109: 111-119
34. Dentelli P, Trombetta A, Togliatto G, et al. Formation of STAT5/PPARgamma transcriptional complex modulates angiogenic cell bioavailability in diabetes. Arterioscler Thromb Vasc Biol 2009;29: 114-120
35. Uberti B, Dentelli P, Rosso A, Defilippi P, Brizzi MF. Inhibition of b1 integrin and IL-3Rb common subunit interaction hinders tumour angiogenesis. Oncogene 2010;29: 6581-6590
36. Shenouda SM, Widlansky ME, Chen K, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 2011;124: 444-453
37. Pipinos II, Judge AR, Selsby JT, et al. The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. Vasc Endovascular Surg 2008;42: 101-112
38. Motta MC, Divecha N, Lemieux M, et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004;116: 551-563
39. Horio Y, Hayashi T, Kuno A, Kunimoto R. Cellular and molecular effects of sirtuins in health and disease. Clin Sci (Lond) 2011;121: 191-203
40. de Kreutzenberg SV, Ceolotto G, Papparella I, et al. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: Potential biochemical mechanisms. Diabetes 2010;59: 1006-1015
41. Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009;458: 1056-1060
42. Gerhart-Hines Z, Rodgers JT, Bare O, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1αlpha. EMBO J 2007;26: 1913-1923
43. Kuang S, Gillespie MA, Rudnicki MA. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008;2: 22-31
44. Baur JA, Ungvari Z, Minor RK, Le Couteur DG, de Cabo R. Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov 2012;11: 443-461
45. Salama R, Sadaie M, Hoare M, Narita M. Cellular senescence and its effector programs. Genes Dev 2014;28: 99-114
46. Mercer J, Bennett M. The role of p53 in atherosclerosis. Cell Cycle 2006;5: 1907-1909
47. Rosso A, Balsamo A, Gambino R, et al. p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J Biol Chem 2006;281: 4339-4347
48. Pinton P, Rimessi A, Marchi S, et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 2007;315: 659-663
49. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol 2012;53: 64-72